Factor XIII Deficiency: A Review of Clinical Presentation and Management

Hematol Oncol Clin North Am. 2021 Dec;35(6):1171-1180. doi: 10.1016/j.hoc.2021.07.009. Epub 2021 Oct 2.

Abstract

Factor XIII (FXIII) deficiency is a rare autosomal recessive disorder that can result in life-threatening bleeding and early fetal loss. FXIII not only is responsible for cross-linking fibrinogen to stabilize and strengthen clot formation but also facilitates wound healing and angiogenesis and plays an important role in fetal vitality. Modern therapeutics allow for prophylactic treatment that can prevent most major bleeding and increasing fetal viability. Early diagnosis is paramount due to the high risk of intracranial bleeding.

Keywords: FXIII deficiency; Hemophilia; Rare bleeding disorder.

Publication types

  • Review

MeSH terms

  • Blood Coagulation Tests
  • Factor XIII / genetics
  • Factor XIII Deficiency* / diagnosis
  • Factor XIII Deficiency* / genetics
  • Factor XIII Deficiency* / therapy
  • Fibrinogen
  • Hemorrhage
  • Humans

Substances

  • Fibrinogen
  • Factor XIII